EP300 and prostate cancer: In 22Rv1 cells, inhibition of both p300 and CBP was necessary to suppress histone acetylation (Extended Data Fig. 3a), suggesting a functional compensation between the paralogs and the need to target both for complete blocking of H2BNTac in prostate cancer.